Q2 2023 Holdings
Filed 2023-08-14 | 7 holdings | $276.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Acelyrin Inc | COM | 00445A100 | $80.6M | 3,857,230 | 29.2% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $72.8M | 9,699,925 | 26.4% |
| Pharvaris N V(PHVS) | COM | N69605108 | $64.6M | 4,264,672 | 23.4% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $36.4M | 1,035,396 | 13.2% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $13.9M | 424,032 | 5.0% |
| Elevation Oncology Inc | COM | 28623U101 | $4.4M | 2,914,255 | 1.6% |
| Impel Pharmaceuticals Inc | COM | 45258K109 | $3.5M | 2,759,791 | 1.3% |